Abingdon Health (LON:ABDX) Trading Down 3.2% – What’s Next?

Abingdon Health Plc (LON:ABDX)’s share price dropped 3.2% during trading on Wednesday . The company traded as low as GBX 7.20 ($0.09) and last traded at GBX 7.50 ($0.09). Approximately 34,747 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 217,851 shares. The stock had previously closed at GBX 7.75 ($0.10).

Abingdon Health Stock Performance

The stock has a market cap of £13.85 million, a price-to-earnings ratio of -899.00 and a beta of 0.13. The stock’s 50 day moving average is GBX 7.94 and its two-hundred day moving average is GBX 9.42. The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64.

About Abingdon Health

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.